Roche (RHHBY) announced that the VENTANA CLDN18 RxDx Assay is the first U.S. Food and Drug Administration approved immunohistochemistry companion diagnostic for determining CLDN18 protein expression ...
OBJECTIVES To determine the sensitivity and specificity of a nephelometric β-trace protein assay for the diagnosis of liquorrhoea. METHODS One hundred and forty clinical samples with suspected ...